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AMAÇ
Bu çal›flmada, metilen mavisinin travmatik tavflan karaci¤eri-
nin vital ve devaskülarize alanlar›n›n ay›r›m› konusundaki et-
kisi araflt›r›ld›.
GEREÇ VE YÖNTEM
Yirmi adet sa¤l›kl› tavflan rastgele iki eflit gruba ayr›ld›. Cer-
rahi ifllem, kar›n üst bölgede orta hattan gerçeklefltirilen 5 cm
u z u n l u ¤ u n d a bir insizyonla uyguland›. Karaci¤er hasar›
oluflturulduktan sonra, portal ven yoluyla dilüe edilmifl meti-
len mavisi enjekte edildi ve boyanmaya bafllanma zamanlar›
ile boyan›n kayboldu¤u zamanlar kaydedildi.
BULGULAR
Yirmi tavflan›n hepsi de deney bitimine kadar yaflad›. Denek-
lerde karaci¤erin perfüze olmayan alanlar› boyanmad›. Kontrol
tavflanlar›nda, karaci¤er parankimi homojen olarak boyand›.
Normal parankimdeki ortalama boyanmaya bafllama zaman›,
deneklerde 18,1±1,3 sn olurken kontrollerde de 17,7±1,4 sn ol-
du (p=AD). Ortalama diskolorasyon zaman›, deneklerde
53,1±3,7 sn ve kontrollerde de 53,1±3,2 sn oldu (p=AD). 
SONUÇ
Cerrahi giriflim gerektiren majör karaci¤er yaralanmalar›nda,
karaci¤erin perfüze olmayan alanlar›n›n saptanmas› için
metilen mavisi enjeksiyonu kullan›labilir.
Anahtar Sözcükler: Karaci¤er nekrozu; metilen mavisi; travma.
BACKGROUND
In this study, the efficacy of methylene blue in the differenti-
ation of devascularized and vital areas in a traumatic liver
model in rabbits was investigated.
METHODS 
Twenty healthy rabbits were selected and randomly divided
into two equal groups. Surgery was performed through an
upper abdominal mid-line incision 5 cm in length. After
induction of liver injury, diluted methylene blue was injected
through the portal vein and staining onset and discoloration
times were recorded.
RESULTS
All 20 rabbits survived until the end of the experiment. In
cases, non-perfused areas of the liver remained unstained. In
control rabbits, liver parenchyma was stained homogeneously.
The mean onset time of staining in normal parenchyma was
18.1±1.3 sec in cases and 17.7±1.4 sec in controls (p=NS).
The mean discoloration time was 53.1±3.7 sec in cases and
53.1±3.2 sec in controls (p=NS).
CONCLUSION
In major liver injuries requiring surgical intervention, methyl-
ene blue injection can be used for detection of non-perfused
areas in the liver.
Key Words: Liver necrosis; methylene blue; trauma.
The spleen and liver are the organs most com-
monly injured in blunt abdominal trauma, with each
accounting for one-third of the injuries. Injury to the
liver is a commonly encountered problem in trauma
and a frequent cause of morbidity and mortality.
Mortality of grade IV and V injuries has been esti-
mated to range between 35% and 80%.[1,2] The initial
hemodynamic status of patients is the main deter-
mining factor for treatment. Nonoperative treatment
of isolated hepatic injury in stable patients is now
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standard practice.[3-5] The management of unstable
patients with liver injury is a multifaceted challenge
requiring various techniques and remains a contro-
versial issue.[6 - 8] S u rgical procedures range from
packing, to anatomic liver resection, to total hepate-
ctomy with liver transplantation.[9-12]
Liver necrosis resulting from devascularization
injuries is an uncommon but life-threatening condi-
tion that has been diagnosed either intraoperatively
or at autopsy.[13-15] Devascularization injuries to the
liver occur when there is disruption of vascular
inflow to one or more hepatic segments.[3] In some
studies, computed tomography (CT) scanning and
magnetic resonance imaging (MRI) were used,[4-12]
but at this time, there is no consensus on the precise
detection of non-perfused areas in the liver intraop-
eratively to help in decision-making. The main
objective of this study was the detection of non-per-
fused areas following liver injury in a rabbit model
using methylene blue (MB) dye.
MATERIALS AND METHODS
The local research ethics committee approved the
study. The experiments were started using 20 New
Zealand white rabbits (10 cases, 10 controls) weigh-
ing 3.5±1.2 kg. The rabbits were housed in a con-
trolled environment with an ambient room tempera-
ture of 24°C and artificial illumination (12-hour
light-dark cycle) for at least two days before starting
the experiment. They were fasted for four hours
before the experiment, but had free access to tap
water. General anesthesia was induced with keta-
mine (35 mg/kg, intramuscularly) and acepromazine
(1.2 mg/kg, intramuscularly) and nitrogen
oxide/oxygen (50%:50%) plus halothane 3%-4% by
means of a cone mask. After endotracheal intuba-
tion, halothane concentration was fixed at 1.5%.
Lactated Ringer’s solution was administered by
means of peripheral intravenous access at 2 ml/kg/hr
during the operation. The rabbits were placed in the
supine position throughout the experiment.
After preparation was made, lidocaine 2% (1
ml/cm3) was injected in the skin of the abdomen.
Surgery was performed through an upper abdominal
mid-line incision 5 cm in length and the liver was
exposed. To induce liver injury in cases imitating
high-grade injury according to the Liver Injury Scale
of the American Association for the Surgery of
Trauma, we used a pair of long pliers with blades
measuring 4.5 cm in length. After inflicting injury,
the portal vein was explored and a disposable sterile
22G catheter was inserted through the vessel into the
proximal vein toward the liver for 3-4 cm. Diluted
2% MB solution (urolene blue 2%, Lexi, USA) 1.5
mg/kg (0.2 ml in 2 ml of normal saline) was inject-
ed through the catheter. After MB injection, the
stained area of the liver was assessed. Staining onset
and discoloration times were also recorded. Then
catheter was removed and a 1-2 cm3 liver sample
was taken from the unstained area at the end of pro-
cedure and was fixed with 4% buffered formalde-
hyde for pathological examination. In terms of
hemostasis, in the presence of uncontrollable bleed-
ing from borders of the injured site, we repaired the
liver injury borders by simple sutures and then the
abdomen was closed. In the postoperative period, if
the general condition of the rabbit was stationary, we
re-operated the animal to control the bleeding. These
processes between the production of the liver injury
and the accomplishment of abdominal closure were
all completed within 30 minutes. For laboratory
analysis, blood samples were taken from a peripher-
al vein preoperatively and 48 hours postoperative for
comparison of serum levels of alanine aminotrans-
ferase (ALT), aspartate aminotransferase (AST),
bilirubin, creatinine and urea. Methemoglobinemia
was assessed by spectrophotometer method.
All data in the text and tables are presented as
mean±SD. Within groups, comparisons of continu-
ous variables were performed using the Wilcoxon
test. The nonparametric Mann-Whitney test was
used to compare variables between groups.
Statistical analyses were performed using SPSS 11
software. The level of statistical significance was set
at p<0.05
RESULTS
The groups were similar in age and sex (male).
There were 10 rabbits with liver injury in the case
group and 10 rabbits in the control group. All 20 rab-
bits survived until the end of the experiment. The
mean body weight of rabbits was 3.5±1.2 kg. There
was no significant difference between the groups
regarding the body weight.
Liver staining data
As shown in Figure 1a, in cases, non-perfused
areas of the liver remained unstained (pink areas),
but the color of the right liver lobe changed from
purple to dark blue. In control rabbits, liver
parenchyma was stained homogeneously (Fig. 1b).
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Table 1 shows staining onset and discoloration times
in controls. The mean onset time of staining in nor-
mal parenchyma was 18.1±1.3 sec in cases and
17.7±1.4 sec in controls (p=NS). The mean discol-
oration time was 53.1±3.7 sec in cases and 53.1±3.2
sec in controls (p=NS).
Biochemical data
Preoperative liver and renal function tests did not
differ between groups (Table 2). In Table 3, bio-
chemical data in the case group were compared pre-
and postoperatively. ALT and AST concentrations
significantly increased postoperatively but renal
function test showed no significant differences. In
comparison of the postoperative biochemical data
between groups (Table 4), ALT and AST concentra-
tions had significantly increased.
Our findings showed no methemoglobinemia in
the groups in postoperative analysis. In evaluation of
the biopsy specimens, hypoperfusion was also histo-
logically proven. 
DISCUSSION
Despite its relatively protected location, the liver
is the most frequently injured intraabdominal organ,
although splenic injuries are more common follow-
ing blunt abdominal trauma.[3]
Fig. 1. (a) Methylene blue staining in a case rabbit. (b) Methylene blue staining in a control rabbit.
(a) (b)
Table 1. Staining onset and discoloration times in control rabbits











Table 2. Preoperative liver and renal function tests in groups 
Cases Controls p
ALT (IU/L) 38.1±8.2 37.9±8.5 NS
AST (IU/L) 47.2±6.3 49.1±5.8 NS
Bilirubin (µmol/L) 0.63±0.31 0.65±0.28 NS 
Urea (mmol/L) 7.3±1.63 7.1±0.98 NS
Creatinine (µmol/L) 134.1±14.2 138±12.3 NS
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; NS: Not significant.
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Associated injuries to other organs, uncontrolled
hemorrhage and septic complications contribute sig-
nificantly to morbidity and mortality. Although mor-
tality rates from liver trauma have reduced over the
past few decades, the surgical management of the
liver remains a challenging problem for surgeons.[6-8]
In 1966, Mays[16] recognized hepatic necrosis as a
potential source of mortality in bursting injuries of
the liver. In his report, 22 of 24 patients died. Smadja
et al.[17] reported on seven patients with major liver
injury initially managed at a referral hospital. Three
of the seven patients died after resection. The author
concluded that patients with extensive liver necrosis
should be brought for definitive surgical resection
before the development of secondary complications.
Several other authors studied the effect of liver
necrosis on mortality,[7,18-20] but only a few reports
have studied its definitive diagnosis.
Hamill et al.[12] showed that MRI of extensive
hepatic necrosis in the cardiovascularly stable trau-
ma patient provides compelling evidence in favor of
hepatic resection.
Anderson et al.[2] proposed a diagnostic and treat-
ment algorithm. In their algorithm, the hemodynam-
ically stable patient would have augmented CT scans
obtained on admission. If significant parenchymal
disruption was determined, the CT scan would be
repeated in 48 hours. If a devascularization injury
was confirmed and there was a worsening or no
improvement in the clinical situation, the patient
would undergo resection after appropriate prepara-
tion. However, the extent of the liver necrosis could
not be assessed definitively during operation and
therefore surgeons would overestimate the bound-
aries of necrosis and extend the liver resection.
Although initially ischemic areas may recover by
developing collateral portal and arterial circulation,
this is a time-consuming process and the surgeon can
not rely on this process for initial liver resection
intraoperatively.
Our study demonstrates that it is possible and
safe to inject MB into the liver intraoperatively. It
also demonstrates that MB is retained in the viable
liver parenchyma and demarcates its necrotic areas.
MB is an antidote in the therapeutic category for
cyanide poisoning and drug-induced methemoglo-
binemia.[21] It is also a genitourinary antiseptic. It has
been used as a vasopressor in sepsis and acute liver
failure. Koelzow et al.[22] reported the effect of MB
on the hemodynamic changes during ischemia-
reperfusion injury in orthotopic liver transplantation.
In his study, no adverse effects were observed using
MB. Although MB is a safe solution, it is contraindi-
cated in history of hypersensitivity to MB, renal
insufficiency or pregnancy. Its adverse reactions are
hypertension, headache, and dizziness, staining of
the skin, nausea and vomiting.[23-26]
To our knowledge, this is the first animal study
Table 3. Pre and postoperative liver and renal function tests in
the case group
Cases Controls p
ALT (IU/L) 38.1± 8.2 64.76±13.4 0.02
AST (IU/L) 47.2± 6.3 97.1±32.1 0.03 
Bilirubin (µmol/L) 0.63±0.31 0.65±0.28 NS  
Urea (mmol/L) 7.3±1.63 7.1±0.98 NS
Creatinine (µmol/L) 134.1±14.2 138±12.3 NS  
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; NS: Not significant.
Table 4. Postoperative liver and renal function tests between
groups
Cases Controls p
ALT (IU/L) 64.76±13.4 39.3±6.1 0.02
AST (IU/L) 97.1±32.1 49.7±6.8 0.02 
Bilirubin (µmol/L) 0.63±0.31 0.65±0.28 NS   
Urea (mmol/L) 7.3±1.63 7.1±0.98 NS
Creatinine (µmol/L) 134.1±14.2 138±12.3 NS  
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; NS: Not significant.
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with severe liver injuries to investigate the benefit of
a new method of necrosis assessment. None of the
rabbits showed complications of MB injection.
Increase in the postoperative ALT and AST concen-
trations in the case group was due to the traumatic
injury to the liver. It is a safe method that rapidly
demarcates necrotic areas of the liver parenchyma
and helps surgeons in the decision-making process.
Although the liver parenchyma is perfused by the
hepatic artery and portal vein, no perfusion occurred
in this area since we occluded all sides of the injured
site.
Therefore, we suggest that MB injection can be
performed in patients with major liver injuries
requiring surgical intervention in suspected cases of
liver necrosis.
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